Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1993 Jul;67(7):4323–4336. doi: 10.1128/jvi.67.7.4323-4336.1993

Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain.

J A Taddie 1, P Traktman 1
PMCID: PMC237803  PMID: 8389930

Abstract

In this report, we describe the isolation, molecular genetic mapping, and phenotypic characterization of vaccinia virus mutants resistant to cytosine arabinoside (araC) and phosphonoacetic acid (PAA). At 37 degrees C, 8 microM araC was found to prevent macroscopic plaque formation by wild-type virus and to cause a 10(4)-fold reduction in viral yield. Mutants resistant to 8 microM araC were selected by serial passage of a chemically mutagenized viral stock in the presence of drug. Because recovery of mutants required that initial passages be performed under less stringent selective conditions, and because plaque-purified isolates were found to be cross-resistant to 200 micrograms of PAA per ml, it seemed likely that resistance to araC required more than one genetic lesion. This hypothesis was confirmed by genetic and physical mapping of the responsible mutations. PAAr was accorded by the acquisition of one of three G-A transitions in the DNA polymerase gene which individually alter cysteine 356 to tyrosine, glycine 372 to aspartic acid, or glycine 380 to serine. AraCr was found to require one of these substitutions plus an additional T-C transition within codon 171 of the DNA polymerase gene, a change which replaces the wild-type phenylalanine with serine. Congenic viral stocks carrying one of the three PAAr lesions, either alone or in conjunction with the upstream araCr lesion, in an otherwise wild-type background were generated. The PAAr mutations conferred nearly complete resistance to PAA, a slight degree of resistance to araC, hypersensitivity to aphidicolin, and decreased spontaneous mutation frequency. Addition of the mutation at codon 171 significantly augmented araC resistance and aphidicolin hypersensitivity but caused no further change in mutation frequency. Several lines of evidence suggest that the PAAr mutations primarily affect the deoxynucleoside triphosphate-binding site, whereas the codon 171 mutation, lying within a conserved motif associated with 3'-5' exonuclease function, is postulated to affect the proofreading exonuclease of the DNA polymerase.

Full text

PDF
4323

Images in this article

4327Image
on p.4327
4329Image
on p.4329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldick C. J., Jr, Moss B. Resistance of vaccinia virus to rifampicin conferred by a single nucleotide substitution near the predicted NH2 terminus of a gene encoding an Mr 62,000 polypeptide. Virology. 1987 Jan;156(1):138–145. doi: 10.1016/0042-6822(87)90444-2. [DOI] [PubMed] [Google Scholar]
  2. Bastow K. F., Derse D. D., Cheng Y. C. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin. Antimicrob Agents Chemother. 1983 Jun;23(6):914–917. doi: 10.1128/aac.23.6.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Basu A., Modak M. J. Identification and amino acid sequence of the deoxynucleoside triphosphate binding site in Escherichia coli DNA polymerase I. Biochemistry. 1987 Mar 24;26(6):1704–1709. doi: 10.1021/bi00380a032. [DOI] [PubMed] [Google Scholar]
  4. Beese L. S., Steitz T. A. Structural basis for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. EMBO J. 1991 Jan;10(1):25–33. doi: 10.1002/j.1460-2075.1991.tb07917.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blanco L., Bernad A., Salas M. Evidence favouring the hypothesis of a conserved 3'-5' exonuclease active site in DNA-dependent DNA polymerases. Gene. 1992 Mar 1;112(1):139–144. doi: 10.1016/0378-1119(92)90316-h. [DOI] [PubMed] [Google Scholar]
  6. Catalano C. E., Allen D. J., Benkovic S. J. Interaction of Escherichia coli DNA polymerase I with azidoDNA and fluorescent DNA probes: identification of protein-DNA contacts. Biochemistry. 1990 Apr 17;29(15):3612–3621. doi: 10.1021/bi00467a004. [DOI] [PubMed] [Google Scholar]
  7. Chen M., Horwitz M. S. Dissection of functional domains of adenovirus DNA polymerase by linker-insertion mutagenesis. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6116–6120. doi: 10.1073/pnas.86.16.6116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chung D. W., Zhang J. A., Tan C. K., Davie E. W., So A. G., Downey K. M. Primary structure of the catalytic subunit of human DNA polymerase delta and chromosomal location of the gene. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11197–11201. doi: 10.1073/pnas.88.24.11197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coen D. M., Fleming H. E., Jr, Leslie L. K., Retondo M. J. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. J Virol. 1985 Feb;53(2):477–488. doi: 10.1128/jvi.53.2.477-488.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coen D. M., Furman P. A., Aschman D. P., Schaffer P. A. Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin. Nucleic Acids Res. 1983 Aug 11;11(15):5287–5297. doi: 10.1093/nar/11.15.5287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Coen D. M., Furman P. A., Gelep P. T., Schaffer P. A. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine. J Virol. 1982 Mar;41(3):909–918. doi: 10.1128/jvi.41.3.909-918.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Condit R. C., Easterly R., Pacha R. F., Fathi Z., Meis R. J. A vaccinia virus isatin-beta-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase. Virology. 1991 Dec;185(2):857–861. doi: 10.1016/0042-6822(91)90559-t. [DOI] [PubMed] [Google Scholar]
  13. DeFilippes F. M. Site of the base change in the vaccinia virus DNA polymerase gene which confers aphidicolin resistance. J Virol. 1989 Sep;63(9):4060–4063. doi: 10.1128/jvi.63.9.4060-4063.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Derbyshire V., Freemont P. S., Sanderson M. R., Beese L., Friedman J. M., Joyce C. M., Steitz T. A. Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA polymerase I. Science. 1988 Apr 8;240(4849):199–201. doi: 10.1126/science.2832946. [DOI] [PubMed] [Google Scholar]
  15. Derbyshire V., Grindley N. D., Joyce C. M. The 3'-5' exonuclease of DNA polymerase I of Escherichia coli: contribution of each amino acid at the active site to the reaction. EMBO J. 1991 Jan;10(1):17–24. doi: 10.1002/j.1460-2075.1991.tb07916.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Derse D., Bastow K. F., Cheng Y. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid. J Biol Chem. 1982 Sep 10;257(17):10251–10260. [PubMed] [Google Scholar]
  17. Derse D., Cheng Y. C. Herpes simplex virus type I DNA polymerase. Kinetic properties of the associated 3'-5' exonuclease activity and its role in araAMP incorporation. J Biol Chem. 1981 Aug 25;256(16):8525–8530. [PubMed] [Google Scholar]
  18. Earl P. L., Jones E. V., Moss B. Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3659–3663. doi: 10.1073/pnas.83.11.3659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Evans E., Traktman P. Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication. J Virol. 1987 Oct;61(10):3152–3162. doi: 10.1128/jvi.61.10.3152-3162.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Freemont P. S., Friedman J. M., Beese L. S., Sanderson M. R., Steitz T. A. Cocrystal structure of an editing complex of Klenow fragment with DNA. Proc Natl Acad Sci U S A. 1988 Dec;85(23):8924–8928. doi: 10.1073/pnas.85.23.8924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Freemont P. S., Ollis D. L., Steitz T. A., Joyce C. M. A domain of the Klenow fragment of Escherichia coli DNA polymerase I has polymerase but no exonuclease activity. Proteins. 1986 Sep;1(1):66–73. doi: 10.1002/prot.340010111. [DOI] [PubMed] [Google Scholar]
  22. Gibbs J. S., Chiou H. C., Bastow K. F., Cheng Y. C., Coen D. M. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6672–6676. doi: 10.1073/pnas.85.18.6672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gibbs J. S., Weisshart K., Digard P., deBruynKops A., Knipe D. M., Coen D. M. Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site. Mol Cell Biol. 1991 Sep;11(9):4786–4795. doi: 10.1128/mcb.11.9.4786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Grimley P. M., Rosenblum E. N., Mims S. J., Moss B. Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J Virol. 1970 Oct;6(4):519–533. doi: 10.1128/jvi.6.4.519-533.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hall J. D., Coen D. M., Fisher B. L., Weisslitz M., Randall S., Almy R. E., Gelep P. T., Schaffer P. A. Generation of genetic diversity in herpes simplex virus: an antimutator phenotype maps to the DNA polymerase locus. Virology. 1984 Jan 15;132(1):26–37. doi: 10.1016/0042-6822(84)90088-6. [DOI] [PubMed] [Google Scholar]
  26. Hall J. D., Furman P. A., St Clair M. H., Knopf C. W. Reduced in vivo mutagenesis by mutant herpes simplex DNA polymerase involves improved nucleotide selection. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3889–3893. doi: 10.1073/pnas.82.11.3889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hall J. D., Wang Y. S., Pierpont J., Berlin M. S., Rundlett S. E., Woodward S. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site. Nucleic Acids Res. 1989 Nov 25;17(22):9231–9244. doi: 10.1093/nar/17.22.9231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ish-Horowicz D., Burke J. F. Rapid and efficient cosmid cloning. Nucleic Acids Res. 1981 Jul 10;9(13):2989–2998. doi: 10.1093/nar/9.13.2989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ito J., Braithwaite D. K. Compilation and alignment of DNA polymerase sequences. Nucleic Acids Res. 1991 Aug 11;19(15):4045–4057. doi: 10.1093/nar/19.15.4045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Katz E., Moss B. Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin. Proc Natl Acad Sci U S A. 1970 Jul;66(3):677–684. doi: 10.1073/pnas.66.3.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kufe D. W., Munroe D., Herrick D., Egan E., Spriggs D. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function. Mol Pharmacol. 1984 Jul;26(1):128–134. [PubMed] [Google Scholar]
  32. Liu P. K., Chang C. C., Trosko J. E., Dube D. K., Martin G. M., Loeb L. A. Mammalian mutator mutant with an aphidicolin-resistant DNA polymerase alpha. Proc Natl Acad Sci U S A. 1983 Feb;80(3):797–801. doi: 10.1073/pnas.80.3.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Meis R. J., Condit R. C. Genetic and molecular biological characterization of a vaccinia virus gene which renders the virus dependent on isatin-beta-thiosemicarbazone (IBT). Virology. 1991 Jun;182(2):442–454. doi: 10.1016/0042-6822(91)90585-y. [DOI] [PubMed] [Google Scholar]
  34. Mikita T., Beardsley G. P. Functional consequences of the arabinosylcytosine structural lesion in DNA. Biochemistry. 1988 Jun 28;27(13):4698–4705. doi: 10.1021/bi00413a018. [DOI] [PubMed] [Google Scholar]
  35. Muzyczka N., Poland R. L., Bessman M. J. Studies on the biochemical basis of spontaneous mutation. I. A comparison of the deoxyribonucleic acid polymerases of mutator, antimutator, and wild type strains of bacteriophage T4. J Biol Chem. 1972 Nov 25;247(22):7116–7122. [PubMed] [Google Scholar]
  36. Nishiyama Y., Yoshida S., Tsurumi T., Yamamoto N., Maeno K. Drug-resistant mutants of herpes simplex virus type 2 with a mutator or antimutator phenotype. Microbiol Immunol. 1985;29(4):377–381. doi: 10.1111/j.1348-0421.1985.tb00837.x. [DOI] [PubMed] [Google Scholar]
  37. Ohno Y., Spriggs D., Matsukage A., Ohno T., Kufe D. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta. Cancer Res. 1988 Mar 15;48(6):1494–1498. [PubMed] [Google Scholar]
  38. Ollis D. L., Brick P., Hamlin R., Xuong N. G., Steitz T. A. Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP. 1985 Feb 28-Mar 6Nature. 313(6005):762–766. doi: 10.1038/313762a0. [DOI] [PubMed] [Google Scholar]
  39. Pacha R. F., Condit R. C. Characterization of a temperature-sensitive mutant of vaccinia virus reveals a novel function that prevents virus-induced breakdown of RNA. J Virol. 1985 Nov;56(2):395–403. doi: 10.1128/jvi.56.2.395-403.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pedrali-Noy G., Spadari S. Mechanism of inhibition of herpes simplex virus and vaccinia virus DNA polymerases by aphidicolin, a highly specific inhibitor of DNA replication in eucaryotes. J Virol. 1980 Nov;36(2):457–464. doi: 10.1128/jvi.36.2.457-464.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Polesky A. H., Steitz T. A., Grindley N. D., Joyce C. M. Identification of residues critical for the polymerase activity of the Klenow fragment of DNA polymerase I from Escherichia coli. J Biol Chem. 1990 Aug 25;265(24):14579–14591. [PubMed] [Google Scholar]
  42. Reha-Krantz L. J. Amino acid changes coded by bacteriophage T4 DNA polymerase mutator mutants. Relating structure to function. J Mol Biol. 1988 Aug 20;202(4):711–724. doi: 10.1016/0022-2836(88)90552-9. [DOI] [PubMed] [Google Scholar]
  43. Reha-Krantz L. J., Bessman M. J. Studies on the biochemical basis of mutation VI. Selection and characterization of a new bacteriophage T4 mutator DNA polymerase. J Mol Biol. 1981 Feb 5;145(4):677–695. doi: 10.1016/0022-2836(81)90309-0. [DOI] [PubMed] [Google Scholar]
  44. Reha-Krantz L. J. Locations of amino acid substitutions in bacteriophage T4 tsL56 DNA polymerase predict an N-terminal exonuclease domain. J Virol. 1989 Nov;63(11):4762–4766. doi: 10.1128/jvi.63.11.4762-4766.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Reha-Krantz L. J., Nonay R. L., Stocki S. Bacteriophage T4 DNA polymerase mutations that confer sensitivity to the PPi analog phosphonoacetic acid. J Virol. 1993 Jan;67(1):60–66. doi: 10.1128/jvi.67.1.60-66.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rempel R. E., Anderson M. K., Evans E., Traktman P. Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J Virol. 1990 Feb;64(2):574–583. doi: 10.1128/jvi.64.2.574-583.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rigby P. W., Dieckmann M., Rhodes C., Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977 Jun 15;113(1):237–251. doi: 10.1016/0022-2836(77)90052-3. [DOI] [PubMed] [Google Scholar]
  48. Roovers D. J., Overman P. F., Chen X. Q., Sussenbach J. S. Linker mutation scanning of the genes encoding the adenovirus type 5 terminal protein precursor and DNA polymerase. Virology. 1991 Jan;180(1):273–284. doi: 10.1016/0042-6822(91)90032-7. [DOI] [PubMed] [Google Scholar]
  49. Rush J., Konigsberg W. H. Photoaffinity labeling of the Klenow fragment with 8-azido-dATP. J Biol Chem. 1990 Mar 25;265(9):4821–4827. [PubMed] [Google Scholar]
  50. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sridhar P., Condit R. C. Selection for temperature-sensitive mutations in specific vaccinia virus genes: isolation and characterization of a virus mutant which encodes a phosphonoacetic acid-resistant, temperature-sensitive DNA polymerase. Virology. 1983 Jul 30;128(2):444–457. doi: 10.1016/0042-6822(83)90269-6. [DOI] [PubMed] [Google Scholar]
  52. Taddie J. A., Traktman P. Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity. J Virol. 1991 Feb;65(2):869–879. doi: 10.1128/jvi.65.2.869-879.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Takanami M. RNA polymerase nascent product analysis. Methods Enzymol. 1980;65(1):497–499. doi: 10.1016/s0076-6879(80)65058-7. [DOI] [PubMed] [Google Scholar]
  54. Tartaglia J., Paoletti E. Physical mapping and DNA sequence analysis of the rifampicin resistance locus in vaccinia virus. Virology. 1985 Dec;147(2):394–404. doi: 10.1016/0042-6822(85)90141-2. [DOI] [PubMed] [Google Scholar]
  55. Traktman P., Kelvin M., Pacheco S. Molecular genetic analysis of vaccinia virus DNA polymerase mutants. J Virol. 1989 Feb;63(2):841–846. doi: 10.1128/jvi.63.2.841-846.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Traktman P., Sridhar P., Condit R. C., Roberts B. E. Transcriptional mapping of the DNA polymerase gene of vaccinia virus. J Virol. 1984 Jan;49(1):125–131. doi: 10.1128/jvi.49.1.125-131.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Traktman P. The enzymology of poxvirus DNA replication. Curr Top Microbiol Immunol. 1990;163:93–123. doi: 10.1007/978-3-642-75605-4_4. [DOI] [PubMed] [Google Scholar]
  58. Vogelstein B., Gillespie D. Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci U S A. 1979 Feb;76(2):615–619. doi: 10.1073/pnas.76.2.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wang T. S. Eukaryotic DNA polymerases. Annu Rev Biochem. 1991;60:513–552. doi: 10.1146/annurev.bi.60.070191.002501. [DOI] [PubMed] [Google Scholar]
  60. Wang Y. S., Woodward S., Hall J. D. Use of suppressor analysis to identify DNA polymerase mutations in herpes simplex virus which affect deoxynucleoside triphosphate substrate specificity. J Virol. 1992 Mar;66(3):1814–1816. doi: 10.1128/jvi.66.3.1814-1816.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Zhang J., Chung D. W., Tan C. K., Downey K. M., Davie E. W., So A. G. Primary structure of the catalytic subunit of calf thymus DNA polymerase delta: sequence similarities with other DNA polymerases. Biochemistry. 1991 Dec 24;30(51):11742–11750. doi: 10.1021/bi00115a002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES